SCHEMBL27769709

SCHEMBL27769709

O=[N+]([O-])c1cnc2ccc(Br)cc2c1-c1ccc(O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 2/20 0.41
MAPT P10636 5/20 0.41
HTT P42858 4/20 0.41
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
TNF P01375 1/20 0.41
POLB P06746 1/20 0.41
CRHBP P24387 1/20 0.41
MAPK1 P28482 1/20 0.41
CRHR2 Q13324 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
NLRP3 Q96P20 1/20 0.40
LMNA P02545 1/20 0.39
P4HB P07237 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9167511 0.82 CRHBP (0.44) MAPTMEN1KMT2ATDP1CRHBP
SCHEMBL358629 0.81 MAPT (0.45) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL27769710 0.80 PTGES (0.45) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL28038007 0.77 ALK (0.46) ALKMAPTHTTALDH1A1MEN1
SCHEMBL28468025 0.76 EGFR (0.42) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL9248753 0.76 TSHR (0.42) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL358123 0.75 EGFR (0.42) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL20319134 0.75 CTSB (0.42) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL1557518 0.75 LMNA (0.41) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL30074880 0.72 PTGES (0.49) MAPTHTTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102796099-A Imidazoquinolines as lipid kinase inhibitors NOVARTIS AG 2012-11-28 CN disclosed
CN-101495477-A Imidazoquinolines as lipid kinase inhibitors NOVARTIS AG (CH) 2009-07-29 CN disclosed